In general, the presence of substantial neurological/psychiatric dysfunction during vomiting episodes can be an important marker to the potential presence of an underlying metabolic disorder, including OTC deficiency, in cases with cyclic vomiting
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study
Introduction Do you ever wonder if the supplements you take can work together to enhance your health
Optimal Dosage and Injection Protocols for CJC1295 CJC1295 is typically dosed once daily or 23 times weekly , depending on the form: CJC1295 with DAC (Drug Affinity Complex): This long-acting version allows for 2 mg injected subcutaneously 12 times per week
Therefore, GLP-1RAs appear to have a beneficial role in the treatment of POCS